Nutrient infusion bypassing duodenum-jejunum improves insulin sensitivity in glucose-tolerant and diabetic obese subjects.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajpendo.00559.2012PMID 23651846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance

  2013cited by this paper
• Insulin Sensitivity and Secretion Changes After Gastric Bypass in Normotolerant and Diabetic Obese Subjects

  2013cited by this paper
• Bariatric surgery versus conventional medical therapy for type 2 diabetes.

  2012cited by this paper
• [Bariatric surgery versus conventional medical therapy for type 2 diabetes].

  2012cited by this paper
• Intestinal transit of a glucose bolus and incretin kinetics: a mathematical model with application to the oral glucose tolerance test.

  2011cited by this paper
• Dissociated incretin hormone response to protein versus fat ingestion in obese subjects

  2011cited by this paper
• IVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach.

  2010cited by this paper
• Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance.

  2009cited by this paper
• First-Phase Insulin Secretion Restoration and Differential Response to Glucose Load Depending on the Route of Administration in Type 2 Diabetic Subjects After Bariatric Surgery

  2009influential reference
• Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery

  2008cited by this paper
• Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

  2008cited by this paper
• Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

  2007cited by this paper
• Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery

  2006cited by this paper
• National trends in bariatric surgery, 1996-2002.

  2006cited by this paper
• beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

  2005cited by this paper
• Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes: A New Perspective for an Old Disease

  2004cited by this paper
• Sabiston Textbook of Surgery

  2004cited by this paper
• Sabiston Textbook of Surgery

  2004cited by this paper
• Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method.

  2004cited by this paper
• Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

  2004cited by this paper
• Bariatric surgery: a systematic review and meta-analysis.

  2004cited by this paper
• Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man.

  2003cited by this paper
• Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance

  2002cited by this paper
• Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models.

  2001cited by this paper
• Ileal absorptive adaptation to jejunal resection and extrinsic denervation: Implications for living-related small bowel transplantation

  2001cited by this paper
• Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans.

  1999cited by this paper
• Glucose-induced thermogenesis in postobese women who have undergone biliopancreatic diversion.

  1994cited by this paper
• Splanchnic Insulin Dynamics and Secretion Pulsatilities in Abdominal Obesity

  1994cited by this paper
• Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients.

  1993cited by this paper
• Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance

  1992cited by this paper
• Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.

  1991cited by this paper
• Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

  1989cited by this paper
• Quantitative study of insulin secretion and clearance in normal and obese subjects.

  1988cited by this paper
• Splanchnic insulin metabolism in obesity. Influence of body fat distribution.

  1986cited by this paper
• Splanchnic and renal metabolism of insulin in human subjects: a dose-response study.

  1983cited by this paper
• Hyperinsulinemia of obesity is due to decreased clearance of insulin.

  1983cited by this paper
• Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data

  1980cited by this paper
• Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

  1980cited by this paper
• A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling.

  1972cited by this paper

• Duodenal mucosal ablation by irreversible electroporation: Modulating the gut-liver axis in metabolic steatotic liver disease

  2025cites this paper
• Enhanced Total Weight Loss 2 Years Post-Roux-en-Y Gastric Bypass with Longer Biliopancreatic Limb

  2025cites this paper
• GLY‐200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double‐blind placebo‐controlled trial

  2025cites this paper
• Intestinal heat shock proteins in metabolic syndrome: Novel mediators of obesity and its comorbidities resolution after metabolic surgery

  2024cites this paper
• Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review.

  2024cites this paper
• The metabolic influence of duodenal mucosal resurfacing for nonalcoholic fatty liver disease

  2023cites this paper
• Role of Proximal Intestinal Glucose Sensing and Metabolism in the Blood Glucose Control in Type 2 Diabetic Rats After Duodenal Jejunal Bypass Surgery

  2022cites this paper
• Neurohormonal Changes in the Gut–Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery

  2022cites this paper
• Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome.

  2021cites this paper
• Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT

  2021cites this paper
• A Gut-Centric Model of Metabolic Homeostasis

  2021cites this paper
• Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial

  2020cites this paper
• Is the jejunum the fulcrum of glucose metabolism?

  2020cites this paper
• Small intestinal metabolism is central to whole-body insulin resistance

  2020cites this paper
• Duodenal mucosal resurfacing: Multicenter experience implementing a minimally invasive endoscopic procedure for treatment of type 2 diabetes mellitus

  2020cites this paper
• Evolving procedural options for the treatment of obesity

  2020cites this paper
• Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device

  2019influential citation
• Proximal and Distal Gut Mucosa Adapt Differently to Westernized Diet, Promoting an Insulin-Resistant Dysmetabolic State

  2019cites this paper
• Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results

  2019cites this paper
• Gut hormone release after gastric bypass depends on the length of the biliopancreatic limb

  2019cites this paper
• Insulin Clearance After Oral and Intravenous Glucose Following Gastric Bypass and Gastric Banding Weight Loss

  2018cites this paper
• Endoscopic Interventions in the Treatment of Obesity and Diabetes

  2018cites this paper
• Gut as an emerging organ for the treatment of diabetes: focus on mechanism of action of bariatric and endoscopic interventions.

  2018cites this paper
• Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission

  2018cites this paper
• Intestinal and Gastric Origins for Diabetes Resolution After Bariatric Surgery

  2018cites this paper
• Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes?

  2017cites this paper
• Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease.

  2017cites this paper
• Small intestinal protein infusion in humans: evidence for a location-specific gradient in intestinal feedback on food intake and GI peptide release

  2017cites this paper
• Endoscopic Medical Devices for Primary Obesity Treatment in Patients With Diabetes

  2017cites this paper
• Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery

  2017cites this paper
• Changes in glycemia, insulin and gut hormone responses to a slowly ingested solid low-carbohydrate mixed meal after laparoscopic gastric bypass or band surgery

  2017cites this paper
• Small intestinal targets involved in food intake regulation : 'from nutrient to satiety signal'

  2016cites this paper
• Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery

  2016influential citation
• Reconfiguration of the small intestine and diabetes remitting effects of Roux-en-Y gastric bypass surgery

  2016cites this paper
• Changes of insulin sensitivity and secretion after bariatric/metabolic surgery.

  2016cites this paper
• Impacto do Comprimento da Ansa Biliopancreática do Bypass Gástrico na Diabetes Tipo 2

  2016cites this paper
• Effects of different milk proteins on the metabolic response in healthy and prediabetic volunteers

  2015cites this paper
• Indications for Bariatric Surgery

  2015cites this paper
• How Does Bariatric Surgery Improve Type II Diabetes? The ''Neglected'' Importance of the Liver in Clearing Glucose and Insulin from the Portal Blood

  2015cites this paper
• Diabetes Remission Following Metabolic Surgery: Is GLP-1 the Culprit?

  2013cites this paper
• World Journal of Hepatology

  year unknowncites this paper